These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30453246)

  • 1. Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria.
    Scarim CB; Jornada DH; Machado MGM; Ferreira CMR; Dos Santos JL; Chung MC
    Eur J Med Chem; 2019 Jan; 162():378-395. PubMed ID: 30453246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thio- and Semicarbazones: Hope in the Search for Treatment of Leishmaniasis and Chagas Disease.
    Silva BV; Silva BNM
    Med Chem; 2017; 13(2):110-126. PubMed ID: 27629824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkaloids with antiprotozoal activity.
    Osorio EJ; Robledo SM; Bastida J
    Alkaloids Chem Biol; 2008; 66():113-90. PubMed ID: 19025098
    [No Abstract]   [Full Text] [Related]  

  • 4. The chemotherapy of protozoal infections of man.
    Steck EA
    J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
    [No Abstract]   [Full Text] [Related]  

  • 5. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
    Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis).
    Bouchikhi F; Anizon F; Brun R; Moreau P
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6319-21. PubMed ID: 21937228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiparasitic therapy.
    Kappagoda S; Singh U; Blackburn BG
    Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 10. Insight into Recent Drug Discoveries against Trypanosomatids and Plasmodium spp Parasites: New Metal-based Compounds.
    Scarim CB; de Farias RL; Chiba DE; Chin CM
    Curr Med Chem; 2022; 29(13):2334-2381. PubMed ID: 34533436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Top Med Chem; 2021; 21(21):1871-1899. PubMed ID: 33797369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
    González M; Cerecetto H
    Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy and prophylaxis of systemic protozoan infections.
    Van Voorhis WC
    Drugs; 1990 Aug; 40(2):176-202. PubMed ID: 2121456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
    Espuelas S; Plano D; Nguewa P; Font M; Palop JA; Irache JM; Sanmartín C
    Curr Med Chem; 2012; 19(25):4259-88. PubMed ID: 22834813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
    Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
    Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives.
    de Oliveira RB; de Souza-Fagundes EM; Soares RP; Andrade AA; Krettli AU; Zani CL
    Eur J Med Chem; 2008 Sep; 43(9):1983-8. PubMed ID: 18222568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
    Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
    PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Amazing World of Peptide Engineering: the Example of Antimicrobial Peptides from Frogs and Their Analogues.
    Guimarães AB; Costa FJ; Pires OR; Fontes W; Castro MS
    Protein Pept Lett; 2016; 23(8):722-37. PubMed ID: 27262306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.